DEA Solicits Information on Gamma-butyrolactone Handling and Industrial Uses

Summary

The Drug Enforcement Administration (DEA) is seeking information on gamma-butyrolactone (GBL), a precursor to gamma-hydroxybutyrate (GHB), which may become a controlled substance under the Controlled Substances Act. The DEA aims to prevent GBL diversion while minimizing disruption to legitimate trade.